HIV-associated mortality is greatly reduced because of the widespread use of efficient antiretroviral therapy. 1 Consequently, in the USA and Europe, patients with HIV-1 infection older than 50 years represent more than 50% of the follow-up population. [2] [3] [4] Similarly, agerelated health problems such as cardiovascular diseases have been increasing with increasing age in patients with HIV because of chronic inflammation, immune activation and immunosenescence, and lifelong antiretroviral therapy. [5] [6] [7] These comorbidities, called non-AIDS-related comorbidities, are more prevalent in patients with HIV infection than people of the same age without HIV, which suggests an extra 'hit' of ageing related to HIV-1 infection and/or antiretroviral therapy, which can lead to geriatric syndromes with impairment and frailty. [8] [9] [10] [11] Osteoarthritis (OA) is the most common rheumatologic disease due to ageing, affecting about six million people with hip and/or knee OA in France 12 and 27 million in the USA. 13 The disease has never been studied in the setting of HIV comorbidities. Among all localisations, hand OA (HOA) is associated with pain, disability and deteriorated quality of life to the same extent as rheumatoid arthritis. [14] [15] [16] However, to what extent HIV-1-positive patients have OA and HOA is unknown.
OA is a heterogeneous group of diseases that can be differentiated by the risk factors (ie, ageing, obesity, trauma). Each factor has specific pathophysiological pathways, all leading to joint destruction. 17 18 Obesity-associated OA is one of the most-studied phenotypes characterised by the association of obesity or overweight with OA on weight-bearing joints due to mechanical overload. 19 However, recently, the demonstration of an association between obesity and HOA has shed light on a potential role of systemic metabolic disturbances in the pathophysiology of OA. 20 Indeed, several studies have raised the possibility of an association of metabolic syndrome (MetS) and OA, but which did not persist after adjustment on body mass index or weight in some of them. [21] [22] [23] In addition to accelerated ageing, patients with HIV infection frequently have MetS because HIV infection, via chronic inflammation and immune activation, which contributes to dyslipidaemia and insulin resistance (IR). 24 Moreover, antiretroviral therapy, especially protease inhibitors, can induce a lipodystrophic syndrome characterised by altered body fat composition, dyslipidaemia and IR 25 and subsequent MetS development. 26 Considering the increased life expectancy, accentuated ageing and high prevalence of MetS in patients with HIV infection, we hypothesised that HOA could represent a novel HIVassociated non-AIDS-related comorbidity. Similarly, we aimed to determine whether MetS might be associated with risk of radiographic HOA in patients with HIV infection and whether the prevalence of HOA in patients with HIV infection is greater than in the general population.
METHODS

Patients
The present study, called Metabolic Syndrome and Fibrosis-Osteoarthritis (METAFIB-OA), is an ancillary study of the METAFIB study (NCT02353767). METAFIB is a cross-sectional single-centre study that recruited 458 patients with HIV infection >18 years old from January 2011 to December 2012 from outpatient clinics. HIV-positive status for at least 5 years was confirmed by Western blot analysis or ELISA in patients without chronic viral hepatitis coinfection to investigate the impact of MetS on liver fibrosis. All patients were HIV-1-positive and were separated in two subgroups, with (HIV-1+MetS+) and without MetS (HIV-1+MetS−). MetS was defined by the International Diabetes Federation (IDF) criteria (see online supplementary table S1). 27 Patients with MetS + were matched to those without MetS+ by sex and age (±5 years), with a ratio of 1:1.
For all patients, metabolic and HIV-1 infection clinical characteristics were recorded at the time of participation to METAFIB-OA cross-sectional study. A fasting blood sample was obtained from all subjects for assessing blood cell count, CD4+ and CD8+ T-cell count, ultrasensitive HIV-1 viral (usHIV-1) load, lipid levels, glycaemia and insulinaemia for homeostasis model assessment IR (HOMA-IR) calculation by the standard procedure of the hospital. The lowest count (nadir) for the CD4+ and CD8+ T cells was extracted from medical files.
Between September 2011 and April 2012, all patients between 45 and 64 years from the METAFIB were contacted for the ancillary METAFIB-OA study. Exclusion criteria were pregnancy, inflammatory rheumatic disease or Dupuytren's disease. To compare the prevalence of HOA between METAFIB-OA patients and the general population, we used data from the Framingham cohort, a population-based cohort consisting of the Offspring and the Community cohorts, in which HOA prevalence had been previously examined. 28 29 The study was approved by the Institutional Review Board (Comité de Protection des Personnes, Paris Ile de France V, Paris). All patients gave informed consent.
Radiographic definition of HOA and severity
For METAFIB-OA study (ie, between September 2011 and April 2012), all patients underwent bilateral postero-anterior hand radiography at 100% at AP-HP Saint-Antoine Hospital, and two trained assessors (A-LT and CR-J) scored an equal number of radiographs. The readers were blinded to clinical data and subgroup (MetS+ or MetS−). Hand radiographs were graded by the Kellgren-Lawrence (KL) grading scale, 30 which assesses the distal interphalangeal (DIP), proximal interphalangeal (PIP), interphalangeal thumb (IP-1), metacarpal (MCP) and first carpometacarpal (CMC-1) joints with a grading system from 0 to 4 (0, no OA; 1, doubtful OA; 2, definite minimal OA; 3, moderate OA; 4, severe OA). Any patient with at least one finger joint scored at KL grade ≥2 was considered to have radiographic HOA. Thumb-base OA was also considered separately as unilateral or bilateral with KL score ≥2 on one or two CMC-1 joints 31 because it is more likely related to loading than the other three joints (DIP, PIP, or MCP). [32] [33] [34] [35] Radiographic severity was assessed by (1) the global KL score (sum of the scores for all joints; range 0-128), (2) number of OA joints (KL ≥2; range 1-32), (3) number of patients with erosive HOA according to the Verbruggen-Veys (VV) anatomical phase score, consisting of five phases with a numerical value representing the evolution of HOA (N, normal joint; S, stationary OA with osteophytes and joint-space narrowing; J, complete loss of joint space in the whole or part of the joint; E, subchondral erosion; R, remodelling of subchondral plate). 36 The DIP, PIP, IP-1 and MCP joints were assessed. Erosive HOA diagnosis was based by the presence of at least one erosive joint on bilateral HOA radiographs (E or R phase).
Before this scoring, both readers (A-LT and CR-J) underwent a training session to assess the interobserver and intraobserver reproducibility with 20 hand radiographs from routine practice. Reproducibility between the readers was estimated first by the Cohen κ coefficient for inter-reader concordance and then by the intraclass correlation coefficient (ICC) for intrareader concordance. For the total KL scale, the scores were 0.64 (95% 95% CI 0.61 to 0.67) and 0.95 (95% CI 0.80 to 0.98), respectively. For the VV score, the ICCs were 0.9 (95% CI 0.91 to 0.99) and 0.98 (95% CI 0.91 to 0.99), respectively.
HOA symptoms
Patients from METAFIB who participated to the ancillary METAFIB-OA study completed a brief standardised questionnaire at the time of radiography about their dominant hand, menopausal status for women and history of psoriasis. For joint pain assessment, the following binary question was asked: "On most days, do you have any pain, aching or stiffness in any of your joints?"
Biomarker assessment
A blood sample was performed at the time of the inclusion in the main METAFIB study, so some months before METAFIB-OA. High-sensitivity C reactive protein (hsCRP) was measured by nephelometry on an IMMAGE analyser (Beckman-Coulter, Villepinte, France). We measured plasma levels of high-sensitive interleukin 6 level, reflecting global inflammation and ageing, soluble CD14 (sCD14) and soluble CD163 (sCD163) (Quantikine ELISA Kit, R&D Systems, Oxford, UK), two markers of monocyte/macrophage activation involved in HIV-related chronic immune activation, 37 and leptin (Quantikine; R&D Systems, Oxford, UK) and total adiponectin (ALPCO, EUROBIO, Les Ulis, France), two adipokines involved in MetS 38 39 and OA. 40 
Statistical analysis
Descriptive data are presented as mean±SD, median (IQR) or number (%). HIV+MetS+ and HIV+MetS− patients and subjects with and without HOA were compared by χ 2 test for categorical variables and Wilcoxon rank-sum test for continuous variables.
We compared HOA prevalence from the METAFIB-OA with the community-based cohort from the Framingham study that estimated HOA prevalence by a slightly modified version of the KL scale (ie, HOA diagnosis with ≥1 joint radiographic OA by a modified KL scale) by χ 2 test by gender and age group.
To determine the factors associated with HOA or thumb-base OA, we calculated crude ORs with 95% CIs by univariate modelling in the entire population. We explored variables related to demographic characteristics, HIV-1 infection features and metabolic disturbances. Variables associated with HOA diagnosis on univariate analysis with p<0.2 were entered in a backward stepwise multivariate conditional logistic regression model. Multivariate linear regression was used to determine factors associated with structural radiographic severity, as defined above (three definitions). MetS was entered in the logistic model along with other variables and kept in the final model, whatever the level of significance. Results are presented as β regression coefficients. All measurements were log-transformed to remove positive skewness and were compared between patients with and without HOA by the Wilcoxon rank-sum test. Univariate and multivariate analyses with a logistic model were adjusted for MetS. All analyses involved use of STATA V.12.1 (StataCorp, College Station, TX, USA) and p<0.05 was considered statistically significant.
RESULTS
Population characteristics
The main METAFIB study included 222 HIV1+MetS+ and 222 HIV1+MetS− subjects; 173 patients with MetS+ and 166 without MetS− 45-64 years old were screened for the METAFIB-OA study (figure 1). Characteristics of the study population are given in table 1, with stratification by MetS status. The two groups did not differ except for all MetS characteristics (p<0.0001), as expected. HOA symptoms were reported by 27% of the population.
HOA prevalence and structural severity in the METAFIB-OA group
Radiographic HOA prevalence and severity are stratified by gender in Considering the differences in sex ratios between the two cohorts and the impact of ageing on OA development, we compared HOA prevalence stratified on sex and age. The prevalence of HOA was significantly higher for men in the METAFIB cohort than men in the Framingham study within each age group. Furthermore, a comparison of age-matched men from the Framingham and the METAFIB cohort by presence and absence of MetS showed that this difference was due to a higher prevalence of HOA in the METAFIB cases (for all ages: 64.9%) than in Framingham subjects (38.7%; p<0.0001). However, we also found greater prevalence of HOA in METAFIB male controls than men from the Framingham study, although not significantly (for all ages, 46.6%, vs 38.7%; p=0.09).
The METAFIB cohort contained few females (n=36), but prevalence of HOA was greater for the METAFIB women than Framingham women, although not significantly (table 3) . Conversely, unilateral or bilateral thumb-base OA frequency did not differ between the METAFIB group and Framingham cohort (data not shown).
Determinants of HOA
In univariate analysis, age, CD4 T-cell count, detectable hsHIV-1 viral load, HOMA-IR, triglycerides level and presence of MetS were associated with HOA (table 4) .
In multivariate analysis, only the presence of MetS (adjusted OR=2.23, 95% CI 1.26 to 3.96; p=0.002) and age (adjusted OR per year=1.18, 95% CI 1.12 to 1.25; p=0.00001) remained independently associated with HOA (see online supplementary figure S1). These two factors were associated with HOA severity (see online supplementary table S2).
Considering each metabolic component separately, only IR assessed by HOMA-IR and triglycerides level was associated but not significantly with HOA on univariate analysis (p=0.06 and 0.07, respectively) but not after adjustment ( 
Association between biological markers and HOA
To further elucidate the mechanism, MetS or HIV-related characteristics, that may favour HOA, we tested a set of metabolic or HIV-related biomarkers. Plasma sCD14 level was significantly higher in patients with HOA than without HOA (2203.8 vs 2010.8 pg/mL; p=0.02) (see online supplementary table S4). This finding was corroborated by univariate analysis finding log (sCD14) level associated with HOA in the whole study population (OR=4.9, 95% CI 1.1 to 21.6; p=0.03). However, after adjustment for MetS, this association became non-significant (OR=3.9, 95% CI 0.9 to 17.2; p=0.07). Plasma levels of adipokines, hsCRP and sCD163 did not differ by HOA diagnosis.
DISCUSSION
In this study, radiographic HOA prevalence was determined for the first time in patients with HIV infection and found to be higher than in the general population from the Framingham cohort. This frequency was further increased in patients with HIV infection with MetS. Age and MetS were associated with HOA during HIV-1 infection. Furthermore, these two factors were also associated with HOA radiographic severity.
Several diseases such as atherosclerosis complications and cancer have emerged as key points in the global therapeutic management of patients with HIV infection. Surprisingly, although OA represents the most common age-related joint disease and with the growing interest in the role of systemic cardiometabolic disturbances in OA pathophysiology, only one preliminary study showed that in 35 HIV-infected men, total body and android fat mass were inversely related to knee cartilage volume measured by MRI. 41 Here, taking advantage of the unique METAFIB study including patients with HIV-1 infection with or without MetS, we observed a higher prevalence of radiographic HOA in patients with HIV infection as compared with the Framingham cohort, representing the general population. Differences between the two cohorts were obvious in men, but the small sample of women limits the power of the statistical analysis. In men, although the prevalence of HOA increased with age in both cohorts, HOA occurred more frequently in patients with HIV-1 infection, especially those with MetS. Interestingly, men from the METAFIB cohort without MetS showed a higher prevalence of HOA, although not significantly, than men from the Framingham cohort in each age group. Such a result emphasises the effect of ageing during HIV infection beyond that of MetS.
Several studies have suggested an association between obesity and HOA. 20 With obesity, the conditions hypertension, dyslipidaemia and glucose intolerance alone or together could increase the risk of OA. In the Rotterdam cohort, 42 the prevalence of HOA was higher in overweight patients with hypertension and diabetes than patients with only overweight. Here, the model of HIV-1 infection further supports the 'metabolic' OA phenotype because the prevalence of HOA was greater in patients with MetS than without MetS. [17] [18] [19] Of note, obesity was not associated with HOA diagnosis in the METAFIB-OA study: such a result agrees with those from the population-based Netherlands Epidemiology of Obesity cohort, finding HOA linked more to metabolic systemic factors than weight itself. 22 Radiographic severity was more severe in patients with MetS, so MetS is a risk factor and also an aggravating factor of radiographic HOA during HIV infection. Radiographic HOA could progress quickly in these patients because radiographic severity is associated with radiographic progression. 43 The association between HIV and HOA complicated by MetS and ageing emphasises the involvement of systemic metabolic inflammatory mediators. Interestingly, plasma sCD14 level was associated with HOA but less so after adjustment for MetS, which suggests that sCD14 and thus macrophage activation induced by MetS could be a link between MetS and HOA and its severity. Of note, plasma sCD14 level is associated with symptoms and radiographic progression in knee OA, and synovial fluid sCD14 level is associated with activated macrophages infiltrating knee synovium. 44 HOA in patients with MetS may have increased synovial inflammation, as is found in patients with knee OA and type 2 diabetes. 45 Separate analyses of thumb-base OA showed that this localisation was not more prevalent in patients with HIV than the general population. Such a result was expected because mechanical factors and the morphology of the trapezo-MCP joint are crucial for this localisation. However, thumb-base OA was more prevalent in patients with HIV with MetS than without MetS. So, metabolic disturbances may represent an additional risk factor, focal mechanical injury being a precipitating event. 46 47 This study has several limitations. First, hand radiography was performed 1 year after assessment of MetS and serum samples taken for examining exploratory markers. However, OA progression is a very slow process, so this bias may have minimal effect on our findings. Second, the Framingham study used the modified version of the KL scoring system, with HOA definition based on the presence of osteophytes and/or definite joint-space narrowing, 29 whereas the original KL scale, used in METAFIB-OA, defined HOA exclusively by the presence of osteophytes. Furthermore, in the Framingham study, the evaluation of OA in the thumb base included assessment of both the CMC-1 and triscaphoid joints, whereas only the CMC-1 joints were assessed in METAFIB-OA. Hence, the scoring system of the Framingham study would classify more joints with definite OA. Consequently, the differences between the two cohorts may have been underestimated. Third, only 25% of patients reported hand pain. However, this frequency agrees with data from other cohorts and OA pain may fluctuate through time. 14 29 Finally, to compare HOA between the French METAFIB-OA group and the general population, we have used the Framingham cohort although characteristics of general population in USA and France are certainly different. However, no HOA assessment in a population-based cohort is available in France until now.
In conclusion, HIV-1 infection represents a special setting in which the risk of radiographic HOA and its severity are increased, due to accelerated ageing and MetS. Beyond classical OA phenotypes, the 'HIV-related OA' subtype could be thus individualised.
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